{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:23:52Z","timestamp":1793496232427,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["21H03170"],"award-info":[{"award-number":["21H03170"]}]},{"name":"JSPS KAKENHI","award":["21H03170"],"award-info":[{"award-number":["21H03170"]}]},{"name":"JST, CREST","award":["JPMJCR22N1"],"award-info":[{"award-number":["JPMJCR22N1"]}]},{"name":"JST, CREST","award":["JPMJCR22N1"],"award-info":[{"award-number":["JPMJCR22N1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adverse event (AE) management is important to improve anti-cancer treatment outcomes, but it is known that some AE signals can be missed during clinical visits. In particular, AEs that affect patients\u2019 activities of daily living (ADL) need careful monitoring as they may require immediate medical intervention. This study aimed to build deep-learning (DL) models for extracting signals of AEs limiting ADL from patients\u2019 narratives. The data source was blog posts written in Japanese by breast cancer patients. After pre-processing and annotation for AE signals, three DL models (BERT, ELECTRA, and T5) were trained and tested in three different approaches for AE signal identification. The performances of the trained models were evaluated in terms of precision, recall, and F1 scores. From 2,272 blog posts, 191 and 702 articles were identified as describing AEs limiting ADL or not limiting ADL, respectively. Among tested DL modes and approaches, T5 showed the best F1 scores to identify articles with AE limiting ADL or all AE: 0.557 and 0.811, respectively. The most frequent AE signals were \u201cpain or numbness\u201d, \u201cfatigue\u201d and \u201cnausea\u201d. Our results suggest that this AE monitoring scheme focusing on patients\u2019 ADL has potential to reinforce current AE management provided by medical staff.<\/jats:p>","DOI":"10.1038\/s41598-023-42496-1","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T13:02:10Z","timestamp":1695128530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adverse event signal extraction from cancer patients\u2019 narratives focusing on impact on their daily-life activities"],"prefix":"10.1038","volume":"13","author":[{"given":"Satoshi","family":"Nishioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntaro","family":"Yada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Aramaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Sayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Kizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"42496_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","volume":"9","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi, C. & Lippi, G. Current cancer epidemiology glossary. J. Epidemiol. Glob. Health 9, 217\u2013222 (2019).","journal-title":"J. Epidemiol. Glob. Health"},{"key":"42496_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10549-017-4317-2","volume":"165","author":"C Lin","year":"2017","unstructured":"Lin, C., Clark, R., Tu, P., Bosworth, H. B. & Zullig, L. L. Breast cancer oral anti-cancer medication adherence: A systematic review of psychosocial motivators and barriers. Breast Cancer Res. Treat. 165, 247\u2013260 (2017).","journal-title":"Breast Cancer Res. Treat."},{"key":"42496_CR3","unstructured":"Ministry of Health, Labour, and Welfare; the manual for handling disorders due to adverse drug reactions. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/iyakuhin\/topics\/tp061122-1.html."},{"key":"42496_CR4","unstructured":"Anderson, W. Guidelines for the management of chemotherapy and systemic anticancer therapy induced toxicities within primary care. Northen Cancer Alliace 0\u201321 (2018)."},{"key":"42496_CR5","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1053\/j.seminoncol.2015.09.032","volume":"42","author":"S Liu","year":"2015","unstructured":"Liu, S. & Kurzrock, R. Understanding toxicities of targeted agents: Implications for anti-tumor activity and management. Semin. Oncol. 42, 863\u2013875 (2015).","journal-title":"Semin. Oncol."},{"key":"42496_CR6","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/eurheartj\/ehs181","volume":"34","author":"TM Suter","year":"2013","unstructured":"Suter, T. M. & Ewer, M. S. Cancer drugs and the heart: Importance and management. Eur. Heart J. 34, 1102\u20131111 (2013).","journal-title":"Eur. Heart J."},{"key":"42496_CR7","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm."},{"key":"42496_CR8","unstructured":"PRO-CTCAE. https:\/\/healthcaredelivery.cancer.gov\/pro-ctcae\/."},{"key":"42496_CR9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","volume":"1","author":"AC Dueck","year":"2015","unstructured":"Dueck, A. C. et al. Validity and reliability of the US national cancer institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). JAMA Oncol. 1, 1051\u20131059 (2015).","journal-title":"JAMA Oncol."},{"key":"42496_CR10","doi-asserted-by":"crossref","unstructured":"Minasian, L. M., Mara, A. O. & Mitchell, S. A. Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials\u202f: Using CTCAE and PRO-CTCAE \u00ae to Provide Two Distinct and Complementary Perspectives. 249\u2013258 (2022).","DOI":"10.2147\/PROM.S256567"},{"key":"42496_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1740774520975120","volume":"18","author":"E Basch","year":"2021","unstructured":"Basch, E. et al. Composite grading algorithm for the national cancer institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Clin. Trials 18, 104\u2013114 (2021).","journal-title":"Clin. Trials"},{"key":"42496_CR12","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/s41416-022-01926-z","volume":"127","author":"GA Watson","year":"2022","unstructured":"Watson, G. A. et al. Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE. Br. J. Cancer 127, 1629\u20131635 (2022).","journal-title":"Br. J. Cancer"},{"key":"42496_CR13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s11914-020-00611-5","volume":"18","author":"RG McGee","year":"2020","unstructured":"McGee, R. G. How to include patient-reported outcome measures in clinical trials. Curr. Osteoporos. Rep. 18, 480\u2013485 (2020).","journal-title":"Curr. Osteoporos. Rep."},{"key":"42496_CR14","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S1470-2045(19)30790-9","volume":"21","author":"C Coens","year":"2020","unstructured":"Coens, C. et al. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: Recommendations of the SISAQOL Consortium. Lancet. Oncol. 21, e83\u2013e96 (2020).","journal-title":"Lancet. Oncol."},{"key":"42496_CR15","doi-asserted-by":"publisher","first-page":"151145","DOI":"10.1016\/j.soncn.2021.151145","volume":"37","author":"KE P\u00e9rez-Alfonso","year":"2021","unstructured":"P\u00e9rez-Alfonso, K. E. & S\u00e1nchez-Mart\u00ednez, V. Electronic patient-reported outcome measures evaluating cancer symptoms: A systematic review. Semin. Oncol. Nurs. 37, 151145 (2021).","journal-title":"Semin. Oncol. Nurs."},{"key":"42496_CR16","first-page":"1","volume":"5","author":"A Nikfarjam","year":"2019","unstructured":"Nikfarjam, A. et al. Early detection of adverse drug reactions in social health networks: A natural language processing pipeline for signal detection. JMIR Public Heal. Surveill. 5, 1\u201311 (2019).","journal-title":"JMIR Public Heal. Surveill."},{"key":"42496_CR17","doi-asserted-by":"publisher","first-page":"e30137","DOI":"10.2196\/30137","volume":"7","author":"J-Y Lee","year":"2021","unstructured":"Lee, J.-Y. et al. The use of social media in detecting drug safety-related new black box warnings, labeling changes, or withdrawals: scoping review. JMIR Public Heal. Surveill. 7, e30137 (2021).","journal-title":"JMIR Public Heal. Surveill."},{"key":"42496_CR18","doi-asserted-by":"publisher","first-page":"e10466","DOI":"10.2196\/10466","volume":"20","author":"M-L K\u00fcrzinger","year":"2018","unstructured":"K\u00fcrzinger, M.-L. et al. Web-based signal detection using medical forums data in France: Comparative analysis. J. Med. Internet Res. 20, e10466 (2018).","journal-title":"J. Med. Internet Res."},{"key":"42496_CR19","doi-asserted-by":"crossref","unstructured":"Bian, J., Topaloglu, U. & Yu, F. Towards large-scale twitter mining for drug-related adverse events. SHB\u201912 Proc. 2012 ACM Int. Work. Smart Heal. Wellbeing Oct. 29, 2012, Maui, Hawaii, USA. Int. Work. Smart Heal. Wellbeing (2012 Maui, Hawaii) 2012, 25\u201332 (2012).","DOI":"10.1145\/2389707.2389713"},{"key":"42496_CR20","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1200\/JCO.2004.03.025","volume":"22","author":"EK Fromme","year":"2004","unstructured":"Fromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y.-C. & Beer, T. M. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 22, 3485\u20133490 (2004).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"42496_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1056\/NEJMp0911494","volume":"362","author":"E Basch","year":"2010","unstructured":"Basch, E. The missing voice of patients in drug-safety reporting. N. Engl. J. Med. 362, 865\u2013869 (2010).","journal-title":"N. Engl. J. Med."},{"key":"42496_CR22","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s11136-020-02558-7","volume":"29","author":"L Liu","year":"2020","unstructured":"Liu, L. et al. Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehabil. 29, 3009\u20133015 (2020).","journal-title":"Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehabil."},{"issue":"3","key":"42496_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/jamia\/ocz200","volume":"27","author":"W Stephen","year":"2020","unstructured":"Stephen, W. et al. Deep learning in clinical natural language processing: A methodical review. J. Am. Med. Inform. Assoc. 27(3), 457\u2013470. https:\/\/doi.org\/10.1093\/jamia\/ocz200 (2020).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"42496_CR24","doi-asserted-by":"publisher","first-page":"103526","DOI":"10.1016\/j.jbi.2020.103526","volume":"109","author":"S Fu","year":"2020","unstructured":"Fu, S. et al. Clinical concept extraction: A methodology review. J. Biomed. Inform. 109, 103526 (2020).","journal-title":"J. Biomed. Inform."},{"key":"42496_CR25","doi-asserted-by":"publisher","first-page":"e12239","DOI":"10.2196\/12239","volume":"7","author":"S Sheikhalishahi","year":"2019","unstructured":"Sheikhalishahi, S. et al. Natural language processing of clinical notes on chronic diseases: systematic review. JMIR Med. Inform. 7, e12239 (2019).","journal-title":"JMIR Med. Inform."},{"key":"42496_CR26","first-page":"1880","volume":"2016","author":"T-T Kuo","year":"2016","unstructured":"Kuo, T.-T. et al. Ensembles of NLP tools for data element extraction from clinical notes. AMIA Annu. Symp. proceedings. AMIA Symp. 2016, 1880\u20131889 (2016).","journal-title":"AMIA Annu. Symp. proceedings. AMIA Symp."},{"key":"42496_CR27","doi-asserted-by":"publisher","first-page":"103301","DOI":"10.1016\/j.jbi.2019.103301","volume":"100","author":"S Datta","year":"2019","unstructured":"Datta, S., Bernstam, E. V. & Roberts, K. A frame semantic overview of NLP-based information extraction for cancer-related EHR notes. J. Biomed. Inform. 100, 103301 (2019).","journal-title":"J. Biomed. Inform."},{"key":"42496_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/jamia\/ocy173","volume":"26","author":"TA Koleck","year":"2019","unstructured":"Koleck, T. A., Dreisbach, C., Bourne, P. E. & Bakken, S. Natural language processing of symptoms documented in free-text narratives of electronic health records: A systematic review. J. Am. Med. Inform. Assoc. 26, 364\u2013379 (2019).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"42496_CR29","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1158\/0008-5472.CAN-19-0579","volume":"79","author":"GK Savova","year":"2019","unstructured":"Savova, G. K. et al. Use of natural language processing to extract clinical cancer phenotypes from electronic medical records. Cancer Res. 79, 5463\u20135470 (2019).","journal-title":"Cancer Res."},{"key":"42496_CR30","first-page":"739","volume":"160","author":"E Aramaki","year":"2010","unstructured":"Aramaki, E. et al. Extraction of adverse drug effects from clinical records. Stud. Health Technol. Inform. 160, 739\u2013743 (2010).","journal-title":"Stud. Health Technol. Inform."},{"key":"42496_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jbi.2015.10.011","volume":"58","author":"X Liu","year":"2015","unstructured":"Liu, X. & Chen, H. A research framework for pharmacovigilance in health social media: Identification and evaluation of patient adverse drug event reports. J. Biomed. Inform. 58, 268\u2013279 (2015).","journal-title":"J. Biomed. Inform."},{"key":"42496_CR32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/jamia\/ocu041","volume":"22","author":"A Nikfarjam","year":"2015","unstructured":"Nikfarjam, A., Sarker, A., O\u2019Connor, K., Ginn, R. & Gonzalez, G. Pharmacovigilance from social media: Mining adverse drug reaction mentions using sequence labeling with word embedding cluster features. J. Am. Med. Informa. Assoc. 22, 671\u2013681 (2015).","journal-title":"J. Am. Med. Informa. Assoc."},{"key":"42496_CR33","first-page":"739","volume":"290","author":"C Kakalou","year":"2022","unstructured":"Kakalou, C., Dimitsaki, S., Dimitriadis, V. K. & Natsiavas, P. Exploiting social media for active pharmacovigilance: The PVClinical social media workspace. Stud. Health Technol. Inform. 290, 739\u2013743 (2022).","journal-title":"Stud. Health Technol. Inform."},{"key":"42496_CR34","unstructured":"Weissenbacher, D. et al. Overview of the Seventh Social Media Mining for Health Applications #SMM4H Shared Tasks at COLING 2022. Proc. Seventh Soc. Media Min. Heal. Work. Shar. Task 221\u2013241 (2022)."},{"key":"42496_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0267901","volume":"17","author":"S Nishioka","year":"2022","unstructured":"Nishioka, S. et al. Identification of hand-foot syndrome from cancer patients\u2019 blog posts: BERT-based deep-learning approach to detect potential adverse drug reaction symptoms. PLoS ONE 17, 1\u201313 (2022).","journal-title":"PLoS ONE"},{"key":"42496_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2196\/37840","volume":"8","author":"T Watanabe","year":"2022","unstructured":"Watanabe, T. et al. Extracting multiple worries from breast cancer patient blogs using multilabel classification with the natural language processing model bidirectional encoder representations from transformers: Infodemiology study of blogs. JMIR Cancer 8, 1\u20139 (2022).","journal-title":"JMIR Cancer"},{"key":"42496_CR37","doi-asserted-by":"publisher","first-page":"103971","DOI":"10.1016\/j.ijmedinf.2019.103971","volume":"132","author":"IJB Young","year":"2019","unstructured":"Young, I. J. B., Luz, S. & Lone, N. A systematic review of natural language processing for classification tasks in the field of incident reporting and adverse event analysis. Int. J. Med. Inform. 132, 103971 (2019).","journal-title":"Int. J. Med. Inform."},{"key":"42496_CR38","first-page":"37","volume":"26","author":"R Jacobsson","year":"2017","unstructured":"Jacobsson, R., Bergvall, T., Sandberg, L. & Ellenius, J. Extraction of adverse event severity information from clinical narratives using natural language processing. Pharmacoepidemiol. Drug Saf. 26, 37 (2017).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"42496_CR39","first-page":"1075","volume":"245","author":"C Liang","year":"2017","unstructured":"Liang, C. & Gong, Y. Predicting harm scores from patient safety event reports. Stud. Health Technol. Inform. 245, 1075\u20131079 (2017).","journal-title":"Stud. Health Technol. Inform."},{"key":"42496_CR40","first-page":"496","volume":"192","author":"G Jiang","year":"2013","unstructured":"Jiang, G., Wang, L., Liu, H., Solbrig, H. R. & Chute, C. G. Building a knowledge base of severe adverse drug events based on AERS reporting data using semantic Web technologies. Stud. Health Technol. Inform. 192, 496\u2013500 (2013).","journal-title":"Stud. Health Technol. Inform."},{"key":"42496_CR41","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/jnci\/djp386","volume":"101","author":"E Basch","year":"2009","unstructured":"Basch, E. et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J. Natl. Cancer Inst. 101, 1624\u20131632 (2009).","journal-title":"J. Natl. Cancer Inst."},{"key":"42496_CR42","unstructured":"Gawlikowski, J. et al. A Survey of Uncertainty in Deep Neural Networks. 1\u201341."},{"key":"42496_CR43","unstructured":"LifePalette. https:\/\/services.mediaid.co.jp\/original-service\/life-palette\/."},{"key":"42496_CR44","unstructured":"ja_sentence_segmenter. https:\/\/github.com\/wwwcojp\/ja_sentence_segmenter."},{"key":"42496_CR45","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera, A. J. & Garrett, J. M. Understanding interobserver agreement: The kappa statistic. Fam. Med. 37, 360\u2013363 (2005).","journal-title":"Fam. Med."},{"key":"42496_CR46","unstructured":"Devlin, J., Chang, M. W., Lee, K. & Toutanova, K. BERT: Pre-training of deep bidirectional transformers for language understanding. NAACL HLT 2019 - 2019 Conf. North Am. Chapter Assoc. Comput. Linguist. Hum. Lang. Technol. - Proc. Conf. 1, 4171\u20134186 (2019)."},{"key":"42496_CR47","unstructured":"Clark, K., Luong, M.-T., Le, Q. V. & Manning, C. D. ELECTRA: Pre-training Text Encoders as Discriminators Rather Than Generators. ICLR 1\u201318 (2020)."},{"key":"42496_CR48","unstructured":"KEKEKE et al. T5: Exploring the limits of transfer learning with a unified text-to-text transformer. J. Mach. Learn. Res. 21, 1\u201367 (2020)."},{"key":"42496_CR49","doi-asserted-by":"publisher","unstructured":"Pathak, A. Comparative analysis of transformer based language models. 165\u2013176 (2021) doi:https:\/\/doi.org\/10.5121\/csit.2021.110111.","DOI":"10.5121\/csit.2021.110111"},{"key":"42496_CR50","unstructured":"cl-tohoku\/bert-japanese. https:\/\/github.com\/cl-tohoku\/bert-japanese."},{"key":"42496_CR51","unstructured":"izumi-lab. https:\/\/huggingface.co\/izumi-lab."},{"key":"42496_CR52","unstructured":"sonoisa\/t5-base-japanese. https:\/\/huggingface.co\/sonoisa\/t5-base-japanese%0A."},{"issue":"3","key":"42496_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/1361684.1361690","volume":"26","author":"DE Losada","year":"2008","unstructured":"Losada, D. E. & Azzopardi, L. Assessing multivariate bernoulli models for information retrieval. ACM Trans. Inform. Syst. 26(3), 1\u201346. https:\/\/doi.org\/10.1145\/1361684.1361690 (2008).","journal-title":"ACM Trans. Inform. Syst."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42496-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42496-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42496-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T16:13:06Z","timestamp":1700410386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42496-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42496"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-42496-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"29 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HY is the chief executive officer of Mediaid Corporation, which operates LifePalette. The other author(s) declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15516"}}